Susan Hasty, Publisher
Table of Contents . . . June 24th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS and HIV Therapy - DC-SIGN could be therapeutic target
Antiviral Cleansing - Plasma treatment appears to be cause of hyperfibrinolysis in transplant recipients
AIDS and HIV Dementia - Cell cycle protein expression altered during HIV encephalitis
AIDS and HIV Therapy - Attenuated infection can create powerful antiviral T cells
AIDS and HIV Therapy - HIV repressor factor linked to viral quiescence
AIDS and HIV Therapy - RNA splicing regulators can be used to modulate viral protein function
AIDS and HIV Vaccine - Herpes simplex vectors can enhance immunogenecity
AIDS Therapy - Preclinical results: Onconase a potential antiviral agent
AIDS Therapy - Roche adds MV026048 to its HIV treatment portfolio
AIDS and HIV Therapy - Access to antiretroviral treatment improving for poor, minority patients
AIDS and HIV Therapy - Grapefruit juice does not affect amprenavir levels
AIDS and HIV Tuberculosis - Patients with negative sputum smear have higher mortality risk
Epidemiology - HIV killing teachers faster than they can be trained
Epidemiology - U.N. says AIDS rapidly reaching epidemic proportions in Asia-Pacific region
Finance - Company reports 17.7% sales increase in the first quarter
HIV Transmission - Prevention regimens in Africa need to deter women from breastfeeding
HIV Transmission - Rapid HIV test for at-risk pregnant women to help reduce infection to newborns
Needlestick Injuries - Horizon gets FDA clearance on new lifeguard safety needle
Policy - AIDS activists optimistic about change in South Africa policy
Policy - African kingdom plans to fight the spread HIV by rewarding virginity
Policy - To help AIDS orphans, prolong life of parents, Population Council researcher tells U.S. lawmakers
Research - Improved treatment in Zimbabwe is goal of collaboration between UB and University of Zimbabwe
Therapy - Product R has multiple potential therapeutic targets
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.